These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7446136)

  • 1. The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.
    Andreasen F; Husted S
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):202-7. PubMed ID: 7446136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of phenprocoumon to human plasma proteins.
    Husted S; Andreasen F
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):206-14. PubMed ID: 506743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the protein binding of drugs by continuous ultrafiltration. 9. Comparison of the binding of nonsteroid antirheumatics to human serum albumin and their interaction with phenprocoumon].
    Rehse K; Fiedler B
    Arch Pharm (Weinheim); 1989 Apr; 322(4):241-3. PubMed ID: 2751413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding of phenprocoumon in the absence and presence of furosemide.
    Foged L; Husted S; Andreasen F
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):312-20. PubMed ID: 989677
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protein binding of drugs determined by continuous ultrafiltration. I. Protein binding of phenprocoumon].
    Rehse K; Rothe M; Maurer R; Kinawi A
    Arch Pharm (Weinheim); 1981 Oct; 314(10):867-74. PubMed ID: 7305640
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the binding of chlorodiazepoxide, diazepam, nitrazepam and phenprocoumon to human and bovine serum albumin (author's transl)].
    Teller C; Kinawi A
    Arch Pharm (Weinheim); 1979 Apr; 312(4):295-8. PubMed ID: 571707
    [No Abstract]   [Full Text] [Related]  

  • 7. The determination of naproxen by spectrofluorometry and its binding to serum proteins.
    Mortensen A; Jensen EB; Petersen PB; Husted S; Andreasen F
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):277-83. PubMed ID: 433621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical studies on the mechanism of the interaction of the enantiomers of the antiocagulant drugs phenprocoumon and warfarin with human serum albumin.
    Brown NA; Jähnchen E; Müller WE; Wollert U
    Mol Pharmacol; 1977 Jan; 13(1):70-9. PubMed ID: 834186
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats.
    Trenk D; Jähnchen E
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):177-91. PubMed ID: 7431221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the protein-binding of drugs with continuous ultrafiltration. 8. In vitro quantification of the interactions of phenprocoumon, warfarin and methylsulfinyl warfarin with phenylbutazone on human serum albumin].
    Rehse K; Ehlert K
    Arch Pharm (Weinheim); 1986 Mar; 319(3):271-4. PubMed ID: 3718179
    [No Abstract]   [Full Text] [Related]  

  • 11. Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon.
    Schmidt W; Jähnchen E
    Experientia; 1978 Oct; 34(10):1323-5. PubMed ID: 104885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic model of the adjustment of phenprocoumon (Falithrom) dosage.
    Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):838-50. PubMed ID: 6083961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of in vivo increase of free fatty acids on human plasma protein binding of furosemide.
    Colombo R; Pinelli A
    Pharmacology; 1982; 25(2):73-81. PubMed ID: 7134262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein binding of furosemide in the elderly.
    Pacifici GM; Viani A; Schulz HU; Frercks HJ
    Eur J Clin Pharmacol; 1987; 32(2):199-202. PubMed ID: 3582485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.
    Vorum H; Jørgensen HR; Brodersen R
    Eur J Clin Pharmacol; 1993; 44(2):157-62. PubMed ID: 8453960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of four sulphonamides to human albumin.
    Zini R; d'Athis P; Hoareau A; Tillement JP
    Eur J Clin Pharmacol; 1976 Jun; 10(2):139-45. PubMed ID: 964290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluorimetric determination of furosemide and 4-chloro-5-sulfamoylanthranilic acid in plasma through direct interpretation of thin layer chromatographs].
    Schäfer M; Geissler HE; Mutschler E
    J Chromatogr; 1977 Nov; 143(6):636-9. PubMed ID: 914954
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilirubin displaces furosemide from serum protein: the effect is greater in newborn infants than adult subjects.
    Viani A; Pacifici GM
    Dev Pharmacol Ther; 1989; 14(2):90-5. PubMed ID: 2630237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of phenprocoumon.
    Haustein KO; Hüller G
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):192-7. PubMed ID: 8032579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.